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ABSTRACT
Introduction. This is the 2016 Annual Report of the University of 
Kansas Health System Poison Control Center (PCC). The PCC is one 
of 55 certified poison control centers in the United States and serves 
the state of Kansas 24 hours a day, 365 days a year, with certified spe-
cialists in poison information and medical toxicologists. The PCC 
receives calls from the public, law enforcement, health care profes-
sionals, and public health agencies. All calls to the PCC are recorded 
electronically in the Toxicall® data management system and uploaded 
in near real-time to the National Poison Data System (NPDS), which 
is the data repository for all poison control centers in the U.S.
Methods. All encounters reported to the PCC from January 1, 2016 
to December 31, 2016 were analyzed. Data recorded for each expo-
sure includes caller location, age, weight, gender, substance exposed 
to, nature of exposure, route of exposure, interventions, medical 
outcome, disposition and location of care. Encounters were classified 
further as human exposure, animal exposure, confirmed non-expo-
sure, or information call (no exposure reported).
Results. The PCC logged 21,965 total encounters in 2016, including 
20,713 human exposure cases. The PCC received calls from every 
county in Kansas. The majority of human exposure cases (50.4%, n = 
10,174) were female. Approximately 67% (n = 13,903) of human expo-
sures involved a child (defined as 19 years or less). Most encounters 
occurred at a residence (94.0%, n = 19,476) and most calls (72.3%, n 
= 14,964) originated from a residence. The majority of human expo-
sures (n = 18,233) were acute cases (exposures occurring over eight 
hours or less). Ingestion was the most common route of exposure 
documented (86.3%, n = 17,882). The most common reported sub-
stance in pediatric encounters was cosmetics/personal care products 
(n = 1,362), followed by household cleaning products (n = 1,301). For 
adult encounters, sedatives/hypnotics/antipsychotics (n = 1,130) and 
analgesics (n = 1,103) were the most frequently involved substances. 
Unintentional exposures were the most common reason for expo-
sures (81.3%, n = 16,836). Most encounters (71.1%, n = 14,732) were 
managed in a non-healthcare facility (i.e., a residence). Among human 
exposures, 14,679 involved exposures to pharmaceutical agents while 
10,176 involved exposure to non-pharmaceuticals. Medical outcomes 
were 32% (n = 6,582) no effect, 19% (n = 3,911) minor effect, 8% (n = 
1,623) moderate effect, and 2% (n = 348) major effects. There were 15 
deaths in 2016 reported to the PCC. Number of exposures, calls from 
healthcare facilities, cases with moderate or major medical outcomes, 
and deaths all increased in 2016 compared to 2015.
Conclusions. The results of the 2016 University of Kansas Health 
System Poison Control annual report demonstrates that the center 
receives calls from the entire state of Kansas totaling over 20,000 
human exposures per year. While pediatric exposures remain the 
most common, there is an increasing number of calls from healthcare 
facilities and for cases with serious outcomes. The experience of the 
PCC is similar to national data. This report supports the continued 
value of the PCC to both public and acute health care in the state of 
Kansas. Kans J Med 2018;11(2):24-33.
INTRODUCTION
  This is the 2016 Annual Report of University of Kansas Health 
System Poison Control Center (PCC). The PCC is a 24-hour, 365 
day/year health care information resource serving the state of Kansas. 
It was founded in 1982 and is certified with the American Association 
of Poison Control Centers (AAPCC). Currently, there are 55 certified 
poison control centers in the United States. The PCC is staffed by 
10 certified specialists in poison information who are either critical 
care trained nurses or doctors of pharmacy. There is 24-hour back up 
provided by board certified medical toxicologists. The PCC receives 
calls from the public, law enforcement, health care professionals, and 
public health agencies. Encounters may involve an exposed animal or 
human (Exposure Call) or a request for information with no known 
exposure (Information Call). The PCC follows all cases to make man-
agement recommendations, monitor case progress, and document 
medical outcome. This information is recorded electronically in the 
Toxicall® data management system and uploaded in near real-time to 
the National Poison Data System (NPDS). NPDS is the data ware-
house for all of the nation’s poison control centers.1 The NPDS utilizes 
a products database that contains over 427,000 products to classify 
exposures. The database is maintained and updated continuously by 
data analysts at the Micromedex Poisindex® System.1 The average 
time to upload data for all PCs is 9.52 minutes, creating a real-time 
national exposure database and surveillance system.1 The PCC has 
the ability to share NPDS real time surveillance with state and local 
health departments and other regulatory agencies. What follows is 
analysis and summary of all encounters reported to the PCC from 
January 1, 2016 to December 31, 2016.
METHODS
 All PCC encounters recorded electronically in the Toxicall® data 
management system from January 1, 2016 to December 31, 2016 were 
analyzed. Cases were first classified as either an exposure or suspect-
ed exposure (Human Exposure, Animal Exposure, Non-Exposure 
Confirmed Cases) or a request for information with no reported expo-
sure (Information Call). Data extracted includes caller location, age, 
weight, gender, exposure substance, number of follow-up calls, and 
nature of exposure (i.e., unintentional, recreational, or intentional). 
Additional data collected included exposure scenario, route of expo-
sure (oral, dermal, parenteral), interventions, medical outcome (no 
effect, minor, moderate, severe, or death), disposition (admitted to 
noncritical care unit, admitted to critical care unit, admitted to psy-
chiatry unit, lost to follow-up, or treated and released) and location of 
care (non-health care facility or health care facility). For this analy-
sis, a pediatric case was defined as any patient 19 years of age or less. 
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the following definitions were used: minor - minimally bothersome 
symptoms, moderate - more pronounced symptoms, usually requiring 
treatment, and major life threatening signs and symptoms.
 Data were analyzed using Microsoft Excel (Microsoft Corp, 
Redmond, WA).
RESULTS
 The PCC logged 21,965 total calls in 2016, including  20,713 human 
exposure cases, 87 non-exposure confirmed cases, 112 animal expo-
sure cases, and 1,053 information calls.  For information calls, drug 
information (n = 308) was most common reason for calling. Table 
1 further describes the encounter types. The PCC made 32,137 fol-
low-up calls in 2016.  Follow-up calls were done in 60.9% of human 
exposure cases. One follow-up call was made in 29.5% of human expo-
sure cases and multiple follow-up calls (range 2 - 44) were made in 
31.3% of cases.  In human exposure calls for which follow-up calls 
were made, an average of 2.54 follow-up calls per case were per-
formed.
Table 1. Encounter type.
Number %
Exposure
Human Exposure 20,713 94.32
Animal Exposure 112 0.51
Subtotal 20,825 94.83
Non-Exposure Confirmed Cases
Human Non-Exposure 87 0.39
Subtotal 87 0.39
Information Call
Drug information 308 1.40
Drug identification 189 0.86
Environmental information 123 0.56
Medical information 30 0.14
Occupational information 1 0.00
Poison information 110 0.50
Prevention/Safety/Education 30 0.14
Teratogenicity information 1 0.00
Other information 49 0.22
Substance abuse 6 0.03
Administrative 16 0.07
Caller referred 190 0.86
Subtotal 1,053 4.78
Total 21,965 100.00
 
 The PCC received calls from all 105 counties in Kansas. The 
county with the most number of calls was Sedgwick County with 
3,358. In addition, calls were received from 47 states, the District 
of Columbia, and 12 calls were from foreign countries, including 
Turkey and Uganda.
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The majority of human exposure cases (50.4%, n = 10,174) were 
female.  A male predominance was found among encounters involving 
children younger than 13 years of age, but this gender distribution was 
reversed in teenagers and adults, with females comprising the major-
ity of reported exposures. Approximately 67% (n = 13,903) of human 
exposures involved a child (defined as age 19 years or less). Table 2 
illustrates distribution of human exposures by age and gender. Figure 
1 demonstrates that patients 1 year of age were the most common age 
group involved in encounters reported to the PCC. For adults, the age 
group of 20 - 29 years old was encountered most commonly (Figure 
2). Seventy-five (75) exposures occurred in pregnant women (0.4% 
of all human exposures). Of these exposures, 26.7% occurred in the 
first trimester, 42.7% occurred in the second trimester, and 28.0% 
occurred in the third trimester. Most of these exposures (78.7%) were 
unintentional exposures and 12.0% were intentional exposures. There 
were no reported deaths to PCC in pregnant women in 2016.
For human exposures, 72.3% (n = 14,964) of calls originated 
from a residence (own or other), while 94.0% (n = 19,476) of these 
exposures actually occurred at a residence (own or other). Calls 
from a health care facility accounted for 21.7% (n = 4,500) of human 
exposure encounters. Table 3 further details the origin of human 
exposure calls and where the exposure took place.
The majority of human exposures (n = 18,233) were acute cases 
(exposures occurring over eight hours or less). Chronic exposures 
(exposures occurring > 8 hours) accounted for 1.6% (327) of all 
human exposures reported. Acute on chronic exposures (single ex-
posure that was preceded by a chronic exposure > 8 hours) totaled 
2063 (9.96%). Ingestion was the most common route of exposure 
documented (86.3%, n = 17,882) in all cases (Table 4).
The most common reported substance in those less than 5 years of 
age was cosmetics/personal care products (n = 1362) followed closely 
by household cleaning products (n = 1,301).  For adult (> 20 years of 
age) encounters, sedatives/hypnotics/antipsychotics (n = 1,130) and 
analgesics (n = 1,103) were the most frequently involved substances. 
Among all encounters, analgesics (n = 2,813, 11%) were the most fre-
quently encountered substance category. Table 5 lists most frequently 
encountered substance categories for pediatric encounters and Table 
6 lists those for adult encounters. [A summary log for all exposures 
categorized by category and sub-category of substance is available 
with the manuscript on the website: kjm.kumc.edu].
There were a total of 399 plant exposures reported to the PCC. The 
most common plant exposure encountered was to pokeweed (Phy-
tolacca Americana; n = 48). Table 7 lists the top 5 most encountered 
plants.
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Figure 1. Distribution of human exposures by gender in children < 19 years old. Figure 2. Distribution of human exposures by gender in adults > 20 years old.
Table 2. Distribution of human exposures by age and gender.
Male Female Unknown Gender Total Cumulative 
Total
Age (yrs.) N Age Group 
Total (%)
N Age Group 
Total (%)
N Age Group 
Total (%)
N Total 
Exposure 
(%)
N %
< 1 619 52.32 526 47.73 1 0.09 1,183 5.71 1,183 5.71
1 1,971 53.26 1,626 46.50 2 0.06 3,701 17.87 4,884 23.58
2 1,773 52.39 1,579 46.30 1 0.03 3,384 16.34 82,68 39.92
3 852 55.32 681 45.49 3 0.20 1,540 7.43 9,808 47.35
4 400 58.48 320 44.02 2 0.28 684 3.30 10,492 50.65
5 245 56.71 204 47.11 0 0.00 432 2.09 10,924 52.74
Unknown < 5 2 33.33 0 0.00 0 0.00 6 0.03 10,930 52.77
Child 6 - 12 768 61.89 470 39.83 1 0.08 1,241 5.99 12,171 58.76
Teen 13 - 19 620 35.98 990 62.15 2 0.13 1,723 8.32 13,894 67.08
Unknown child 5 55.56 7 46.67 0 0.00 9 0.04 13,903 67.12
Subtotal 7,255 52.18 6,403 47.58 12 0.09 13,903 67.12 13,903 67.12
20 - 29 841 47.30 924 52.77 1 0.06 1,778 8.58 15,681 75.71
30 - 39 577 41.72 747 56.12 2 0.15 1,383 6.68 17,064 82.38
40 - 49 447 42.53 558 56.94 3 0.31 1,051 5.07 18,115 87.46
50 - 59 364 40.40 565 57.77 0 0.00 901 4.35 19,016 91.81
60 - 69 292 39.25 411 57.97 1 0.14 744 3.59 19,760 95.40
70 - 79 166 37.22 260 59.50 1 0.23 446 2.15 20,206 97.55
80 - 89 81 33.20 150 64.94 1 0.43 244 1.18 20,450 98.73
> 90 12 32.43 40 67.80 0 0.00 37 0.18 20,487 98.91
Unknown adult 47 36.43 107 66.88 1 0.63 129 0.62 20,616 99.53
Subtotal 2,827 42.11 3,762 56.69 10 0.15 6,713 32.41 20,616 99.53
Total* 10,096 48.74 10,174 50.59 26 0.13 20,713 100.00 20,713 100.00
*Total includes 97 unknown age cases.
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cases.
Site Origin of Call Site of Exposure
N % N %
Residence
Own 14,583 70.41 18,708 90.32
Other 381 1.84 768 3.71
Workplace 324 1.56 395 1.91
Health care facility 4,500 21.73 71 0.34
School 54 0.26 242 1.17
Restaurant/Food service 8 0.04 30 0.14
Public area 63 0.30 181 0.87
Other 775 3.74 164 0.79
Unknown 25 0.12 154 0.74
Table 4. Route of human exposures.
Human Exposures
Route N % of All 
Routes
% of All 
Cases
Ingestion 17,882 82.44 86.33
Dermal 1,312 6.05 6.33
Inhalation/nasal 1,095 5.05 5.29
Ocular 855 3.94 4.13
Bite/sting 215 0.99 1.04
Unknown 157 0.72 0.76
Parenteral 115 0.53 0.56
Other 25 0.12 0.12
Otic 17 0.08 0.08
Rectal 8 0.04 0.04
Aspiration (with ingestion) 5 0.02 0.02
Vaginal 5 0.02 0.02
Total Number of Routes 21,691 100.00 104.72*
*Some cases may have multiple routes of exposure documented.
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Table 5. Substance categories frequently involved in exposures 
for < 5 years old. 
Substance Category All 
Substances
% Single 
Substance 
Exposures
%
Cosmetics/Personal 
care products
1,362 11.89 1,333 12.62
Cleaning substances 
(household)
1,301 11.36 1,259 11.92
Analgesics 1,073 9.37 966 9.14
Foreign bodies/Toys/
Misc.
610 5.32 589 5.57
Antihistamines 590 5.15 537 5.08
Topical preparations 577 5.04 572 5.41
Vitamins 510 4.45 466 4.41
Dietary supplements/
Herbals/Homeopathic
430 3.75 401 3.80
Pesticides 418 3.65 408 3.86
Plants 282 2.46 260 2.46
Gastrointestinal 
preparations
276 2.41 246 2.33
Cold and cough 
preparations
250 2.18 228 2.16
Antimicrobials 241 2.10 213 2.02
Hormones and 
hormone antagonists
227 1.98 157 1.49
Cardiovascular drugs 213 1.86 131 1.24
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Table 6. Substance categories frequently involved in exposures 
of adults (> 20 years old). 
Substance Category All 
Substances
% Single 
Substance 
Exposures
%
Sedative/Hypnotics/
Antipsychotics
1,130 11.65 319 6.14
Analgesics 1,103 11.37 508 9.77
Antidepressants 786 8.10 248 4.77
Cardiovascular drugs 654 6.74 223 4.29
Pesticides 434 4.47 378 7.27
Cleaning substances 
(household)
405 4.18 314 6.04
Alcohols 403 4.15 55 1.06
Anticonvulsants 378 3.90 111 2.14
Antihistamines 333 3.43 151 2.91
Hormones and 
hormone antagonists
272 2.80 135 2.60
Stimulants and street 
drugs
267 2.75 116 2.23
Chemicals 233 2.40 205 3.94
Cosmetics/Personal 
care products
210 2.16 188 3.62
Cold and cough 
preparations
197 2.03 101 1.94
Muscle relaxants 190 1.96 67 1.29
Table 7. Top 5 most frequent plant exposures.
Botanical Name or Category N
Phytolacca americana (L.) (Pokeweed) 48
Plants: Unknown Toxic Types or Unknown if Toxic 46
Spathiphyllum species (Peace Lily) 14
Philodendron (Species unspecified) 16
Cherry (Species unspecified) 12
Unintentional exposures were the most common reason for expo-
sures (81.3%, n = 16,836) while intentional exposures accounted for 
16.3% (n = 3,377) of exposures. Table 8 lists reasons for human expo-
sures. A majority of unintentional exposures (n = 10,897) occurred in 
the less than 5-years-old age group. Up to age 12, 98.9% (n = 12,171) of 
ingestions were unintentional. However, in the 13 - 19 year-old group, 
intentional exposure was most common (63.1%, n = 1,087). In total, 
suspected suicide attempts accounted for 11.7% (n = 2,415) of human 
encounters. When a therapeutic error was the reason for exposure, a 
double dose was the most common scenario (n = 775).
Most encounters (71.1%, n = 14,732) were managed in a non-health 
care facility (i.e., a residence).  Of the 5,747 encounters managed at a 
health care facility, 42% (n = 2,419) were admitted. Table 9 lists the 
management site of all human encounters.
Table 8. Reason for human exposure cases. 
Reason N % Human Exposures
Unintentional
General 11,971 57.8
Therapeutic error 2,361 11.4
Misuse 1,226 5.9
Environmental 625 3.0
Occupational 238 1.1
Bite/sting 217 1.0
Food poisoning 160 0.8
Unknown 38 0.2
Subtotal 16,836 81.3
Intentional
Suspected suicide 2,415 11.7
Misuse 527 2.5
Abuse 348 1.7
Unknown 87 0.4
Subtotal 3,377 16.3
Adverse Reaction
Drug 286 1.4
Other 44 0.2
Food 29 0.1
Subtotal 359 1.7
Unknown Reason 77 0.4
Subtotal 77 0.4
Other
Malicious 43 0.2
Contamination/Tampering 15 0.1
Withdrawal 6 0.0
Subtotal 64 0.3
Total 20,713 100.0
Table 9. Management site of human exposures.
Site of Management N %
Managed in healthcare facility
Treated/evaluated and released 3,153 15.2
Admitted to critical care unit 1,281 6.2
Admitted to noncritical care unit 721 3.5
Admitted to psychiatric facility 417 2.0
Patient lost to follow-up/left AMA 175 0.8
Subtotal (managed in HCF) 5,747 27.8
Managed on site, non-health care facility 14,732 71.1
Other 19 0.1
Refused referral 197 1.0
Unknown 18 0.1
Total 20,713 100.0
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while 10,176 involved exposure to non-pharmaceuticals. Because 
an encounter could include both a pharmaceutical agent and non-
pharmaceutical agent, this total is greater than the total number of 
encounters. However, 88.5% (n = 18,327) of all human exposures were 
exposed to only a single substance. Among these single substance 
exposures, the reason for exposure was intentional in 19.3% (n = 
3,527) of pharmaceutical-only cases compared to 3.5% (n = 641) of 
non-pharmaceutical single substance exposures.
When medical outcomes were analyzed, 32% (n = 6,582) of human 
exposures had no effect, 19% (n = 3,911) had minor effect, 8% (n = 
1,623) had moderate effect, and 2% (n = 348) had major effects. Mod-
erate and major effects were more common in those over 20 years 
of age and in those with intentional encounters. More serious out-
comes were related to single-substance pharmaceutical exposures, 
accounting for 66.7% (n = 10) of the fatalities. Table 10 lists all medical 
outcomes by age and Table 11 lists them by reason for exposure.
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Use of decontamination and specific therapies, including antidotal 
therapy, is detailed in Tables 12a and 12b.
There were 15 deaths in 2016 reported to the PCC. Fourteen of 
the deaths involved patients 20 years of age or older. Fourteen of the 
death cases involved intentional exposures. Table 13 details the 15 
reported deaths.
Table 14 compares key statistics from 2015 to 2016.  Number of 
exposures, calls from healthcare facilities, moderate or major out-
comes, and deaths increased from 2015.
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Table 10. Medical outcomes of human exposure cases by patient age.
< 5 yrs 6 - 12 yrs
      
13 - 19 yrs > 20 yrs
       
Unknown 
child
Unknown 
adult
Unknown 
age
Total
Outcome N % N % N % N % N % N % N % N %
No effect 4,515 41.31 386 31.10 426 24.72 1,244 18.89 0 0.00 9 6.98 2 2.1 6,582 31.78
Minor effect 1,268 11.60 245 19.74 560 32.50 1,805 27.41 1 11.11 27 20.93 5 5.2 3,911 18.88
Moderate effect 92 0.84 39 3.14 309 17.93 1,112 16.89 0 0.00 2 1.55 69 71.1 1,623 7.84
Major effect 10 0.09 4 0.32 66 3.83 268 4.07 0 0.00 0 0.00 0 0.0 348 1.68
Death 0 0.00 0 0.00 1 0.06 12 0.18 0 0.00 0 0.00 0 0.0 13 0.06
No follow-up, 
nontoxic
435 3.98 31 2.50 10 0.58 39 0.59 0 0.00 2 1.55 1 1.0 518 2.50
No follow-up, 
minimal toxicity
4,305 39.39 504 40.61 242 14.05 1,542 23.42 4 44.44 53 41.09 8 8.3 6,658 32.14
No follow-up, 
potentially toxic
207 1.89 16 1.29 73 4.24 281 4.27 3 33.33 24 18.60 10 10.3 614 2.96
Unrelated effect 98 0.90 16 1.29 36 2.09 279 4.24 1 11.11 12 9.30 2 2.1 444 2.14
Death, indirect 
report
0 0.00 0 0.00 0 0.00 2 0.03 0 0.00 0 0.00 0 0.0 2 0.01
Total 10,930 100.00 1,241 100.00 1,723 100.00 6,584 100.00 9 100.00 129 100.00 97 100.00 20,713 100.00
Table 11. Medical outcome by reason for exposure in human exposures.
 Unintentional Intentional Other Adverse reaction Unknown Total
Outcome N % N % N % N % N % N %
Death 0 0.00 13 0.38 0 0.00 0 0.00 0 0.00 13 0.06
Death, indirect report 0 0.00 1 0.03 0 0.00 0 0.00 1 1.30 2 0.01
Major effect 53 0.31 273 8.08 0 0.00 9 2.51 13 16.88 348 1.68
Minor effect 2,746 16.31 1,012 29.97 19 29.69 121 33.70 13 16.88 3,911 18.88
Moderate effect 574 3.41 978 28.96 5 7.81 46 12.81 20 25.97 1,623 7.84
No effect 5,836 34.66 720 21.32 7 10.94 14 3.90 5 6.49 6,582 31.78
No follow-up, nontoxic 512 3.04 4 0.12 1 1.56 1 0.28 0 0.00 518 2.50
No follow-up, minimal toxicity 6,399 38.01 146 4.32 17 26.56 92 25.63 4 5.19 6,658 32.14
No follow-up, potentially toxic 391 2.32 189 5.60 7 10.94 16 4.46 11 14.29 614 2.96
Unrelated effect 325 1.93 41 1.21 8 12.50 60 16.71 10 12.99 444 2.14
Total 16,836 100.00 3,377 100.00 64 100.00 359 100.00 77 100.00 20,713 100.00
KANSAS JOURNAL of  M E D I C I N E
30
POISON CONTROL CENTER ANNUAL REPORT 
continued.
Table 12a. Decontamination provided in human exposures by age.
Decontamination < 5 yrs 6 - 12 yrs 13 - 19 yrs > 20 yrs Unknown child Unknown adult Unknown age Total
Cathartic 2 3 40 46 0 0 0 91
Charcoal, multiple doses 1 2 9 5 0 0 0 17
Charcoal, single dose 87 14 176 202 0 0 0 479
Dilute/irrigate/wash 8,317 796 445 2,649 7 58 3 12,275
Food/snack 1,516 142 83 369 0 3 1 2,114
Fresh air 67 35 37 403 3 26 3 574
Lavage 0 0 1 6 0 0 0 7
Other emetic 57 6 4 39 0 1 0 107
Whole bowel irrigation 0 0 1 8 0 0 0 9
Table 12b. Therapy provided in human exposures by age.
Therapy < 5 yrs 6 - 12 yrs 13 - 19 yrs > 20 yrs Unknown child Unknown adult Unknown age Total
Alkalinization 4 2 39 143 0 0 0 188
Antiarrhythmic 0 1 0 5 0 0 0 6
Antibiotics 27 10 19 185 0 2 0 243
Anticonvulsants 0 0 2 5 0 0 0 7
Antiemetics 16 9 128 177 0 0 0 330
Antihistamines 19 8 21 86 0 0 1 135
Antihypertensives 0 0 1 18 0 0 0 19
Antivenin (fab fragment) 1 1 2 8 0 0 0 12
Antivenin/antitoxin 0 1 4 10 0 0 0 15
Atropine 0 1 1 12 0 0 0 14
Benzodiazepines 17 7 93 270 0 0 0 387
Bronchodilators 2 5 2 48 0 2 69 128
Calcium 164 8 3 31 0 0 0 206
CPR 0 0 2 7 0 0 0 9
Deferoxamine 0 0 0 2 0 0 0 2
Ethanol 0 0 0 1 0 0 0 1
Extracorp. procedure (other) 0 0 0 1 0 0 0 1
Fab fragments 0 0 0 8 0 0 0 8
Fluids, IV 57 23 490 1,313 0 1 1 1,885
Flumazenil 0 1 6 33 0 0 0 40
Fomepizole 4 0 2 15 0 0 0 21
Glucagon 1 0 4 25 0 0 0 30
Glucose, > 5% 4 0 1 42 0 0 0 47
Hemodialysis 0 0 3 21 0 0 0 24
Hydroxocobalamin 3 1 0 1 0 0 0 5
Hyperbaric oxygen 0 0 0 2 0 0 0 2
Insulin 0 0 1 23 0 0 0 24
Intubation 3 3 27 153 0 0 0 186
Methylene blue 0 0 0 3 0 0 0 3
NAC, IV 1 0 63 105 0 0 0 169
NAC, PO 1 1 14 19 0 0 0 35
Naloxone 5 1 23 131 0 0 0 160
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Table 12b. Continued.
Table 13. Details on deaths and exposure related fatalities. 
Age & Gender Substances Substance Rank Cause Rank Chronicity Route Reason
NON-PHARMACEUTICAL EXPOSURES
Fumes/Gases/Vapors
17 year Male Carbon Monoxide 1 1 Acute Inhal Int-S
Heavy Metals
68 year Female Copper 1 1 Acute Ingst Int-S
PHARMACEUTICAL EXPOSURES
Analgesics
73 year Male Acetaminophen/ Hydrocodone 1 1 Acute on Chronic Ingst Int-S
Zolpidem 2 2 Acute on Chronic Ingst
Antihistamines
38 year Female Diphenhydramine 1 1 Acute Ingst Int-S
Cardiovascular Drugs
21 year Female Labetalol 1 1 Unknown Ingst Int-S
Clonazepam 2 2 Unknown Ingst
45 year Female Propranolol 1 1 Acute Ingst Int-S
Valproic Acid 2 2 Acute Ingst
Olanzapine 3 3 Acute Ingst
Bupropion 4 4 Acute Ingst
46 year Male Amlodipine 1 1 Acute on Chronic Ingst Int-S
Lamotrigine 2 2 Acute on Chronic Ingst
Metformin 3 3 Acute on Chronic Ingst
Citalopram 4 4 Acute on Chronic Ingst
Fenobibrate 5 5 Acute on Chronic Ingst
Alpha Blocker 6 6 Acute on Chronic Ingst
Quetiapine 7 7 Acute on Chronic Ingst
Lisinopril 8 8 Acute on Chronic Ingst
Bupropion (Extended Release) 9 9 Acute on Chronic Ingst
Ethanol 10 10 Acute on Chronic Ingst
31
Therapy < 5 yrs 6 - 12 yrs 13 - 19 yrs > 20 yrs Unknown child Unknown adult Unknown age Total
Neuromuscular blocker 2 0 0 6 0 0 0 8
Octreotide 1 0 0 0 0 0 0 1
Other 55 16 99 357 2 3 0 532
Oxygen 9 8 56 379 0 0 69 521
Physostigmine 0 0 4 9 0 0 0 13
Phytonadione 0 0 1 12 0 0 0 13
Sedation (other) 6 5 26 136 0 0 0 173
Sodium thiosulfate 1 0 0 0 0 0 0 1
Steroids 8 2 7 77 0 1 69 164
Vasopressors 0 1 8 65 0 0 0 74
Ventilator 3 3 27 155 0 0 0 188
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Table 13. Continued.
Age & Gender Substances Substance Rank Cause Rank Chronicity Route Reason
46 year Female Propranolol 1 1 Acute Ingst Int-S
Trazodone 2 2 Acute Ingst
Paroxetine 3 3 Acute Ingst
60 year Male Carvedilol 1 1 Acute on Chronic Ingst Int-S
Amlodipine 2 2 Acute on Chronic Ingst
Hydrochlorothiazide/Lisinopril 3 3 Acute on Chronic Ingst
Clopidogrel 4 4 Acute on Chronic Ingst
Duloxetine 5 5 Acute on Chronic Ingst
Acetaminophen/Hydrocodone 6 6 Acute on Chronic Ingst
Dexlansoprazole 7 7 Acute on Chronic Ingst
Quetiapine 8 8 Acute on Chronic Ingst
73 year Female Metoprolol 1 1 Acute on Chronic Ingst Int-S
Duloxetine 2 2 Acute on Chronic Ingst
Trazodone 3 3 Acute on Chronic Ingst
Donepezil 4 4 Acute on Chronic Ingst
Baclofen 5 5 Acute on Chronic Ingst
Benztropine 6 6 Acute on Chronic Ingst
Lurasidone 7 7 Acute on Chronic Ingst
Alprazolam 8 8 Acute on Chronic Ingst
Zolpidem 9 9 Acute on Chronic Ingst
Meloxicam 10 10 Acute on Chronic Ingst
Salicylate 11 11 Acute on Chronic Ingst
Levothyroxine 12 12 Acute on Chronic Ingst
Omeprazole 13 13 Acute on Chronic Ingst
Vitamin D 14 14 Acute on Chronic Ingst
96 year Female Calcium Antagonist 1 1 Acute Ingst Unk
Cold and Cough Preparations
30 year Male Dextromethorphan/Guaifenesin 1 1 Acute Ingst Int-U
Electrolytes And Minerals
63 year Female Iron 1 1 Acute on Chronic Ingst Int-S
Ibuprofen 2 2 Acute on Chronic Ingst
Levothyroxine 3 3 Acute on Chronic Ingst
Sedative/Hypnotics/Antipsychotics
48 year Female Quetiapine 1 1 Acute on Chronic Ingst Int-S
Stimulants and Street Drugs
20 year Male Heroin 1 1 Acute on Chronic Par Int-A
Ethanol 2 2 Acute on Chronic Ingst
Abbreviations: Inhal: Inhalation; Ingst: Ingestion; Par: Parenteral; Int-S: Intentional-Self; Int-U; Intentional-Unknown; Int-A: Intentional-Another; Unk: 
Unknown.
KANSAS JOURNAL of  M E D I C I N ETable 14 compares key statistics from 2015 to 2016.  Number of 
exposures, calls from healthcare facilities, moderate or major out-
comes and deaths increased from 2015.
Table 14. 2015 to 2016 comparison of select statistics.
2015 2016
Total Cases 20,109 21,965
Calls from Health Care Facility 4,267 4,514
Moderate or Major Outcomes 1,688 1,971
Deaths 13 15
DISCUSSION
The University of Kansas Health System Poison Control Center 
has been in operation for 35 years and serves the state of Kansas 24 
hours a day, 365 days a year.  Receiving over 26,000 calls per year, the 
PCC is an integral part of the emergency medical response, public 
health and health care facilities in Kansas.  Childhood poisonings, 
both unintentional and intentional, are a major focus, with calls for 
patients under 19 years of age accounting for approximately 2/3 of 
all exposures.  
The PCC statistics are similar to those seen nationally.1 In 2016, 
2,710,042 encounters were logged by poison control centers nation-
wide, including 2,159,032 human exposures. Total encounters 
showed a 2.9% decline from 2015, but healthcare facility (HCF) 
human exposure cases increased by 3.6% from 2015. More serious 
outcomes (moderate, major, or death) also increased. Nationwide, 
the five substance classes most frequently involved in adult exposures 
were analgesics, sedative/hypnotics/antipsychotics, antidepressants, 
cardiovascular drugs, and cleaning substances, while the top five most 
common exposures in children age 5 years or less were cosmetics/
personal care products, household cleaning substances, analgesics, 
foreign bodies/toys/miscellaneous, and topical preparations.  There 
were 1,415 exposure related fatalities reported nationwide in 2016.
The ongoing importance of the PCC is reflected in current trends 
that have seen rates of poisonings and overdoses increase at an alarm-
ing rate. The PCC saw an increase in number of calls from healthcare 
facilities, cases with moderate or major medical outcomes and deaths 
in 2016 compared to 2015. In an August 2017 report, the National 
Center for Health Statistics noted that the age-adjusted drug-poi-
soning death rate increased from 6.1 per 100,000 in 1999 to 16.3 per 
100,000 in 2015, totaling over 50,000 deaths in 2015.3 Teenage (age 
15 - 19) overdose deaths are increasing as well.4 The ongoing “opioid 
epidemic” is a major driver in the rise of poisoning deaths.3
Reporting exposures to the PCC is voluntary and the PCC is not 
contacted for all poisonings in the state of Kansas. Furthermore, in 
a majority of cases there is no objective confirmation of exposure. 
These limitations should be noted when interpreting PCC data.
CONCLUSION
The results of the 2016 University of Kansas Health System Poison 
Control annual report demonstrated that the center receives calls 
from the entire state of Kansas, totaling over 20,000 human expo-
sures per year. While pediatric exposures remain the most common, 
there is an increasing number of calls from healthcare facilities and
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for cases with serious outcomes. The experience of the PCC is similar 
to national data. This report supports the continued value of the PCC 
to both public and acute health care in the state of Kansas.
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